Andrés Tirado-Sánchez
Department of Dermatology, Hospital General de Mexico and Instituto Mexicano del Seguro Social, Mexico

Series: Dermatology – Laboratory and Clinical Research
BISAC: SCI013040

The main objective in treating pemphigus vulgaris is to control the disease, prevent relapses, and avoid adverse events associated with the prolonged use of steroids and immunosuppressive agents. Finding the most effective steroid-sparing agent has formed much of the focus of recent research. Systemic corticosteroids remain the gold standard for pemphigus vulgaris. In this book, the reader will have a complete view of this group of life-threatening diseases through direct images, tables and text. This book is not only of interest to dermatologists, but for all those health professionals whom at some point in their lives have tried or at least had the opportunity to see a patient with these diseases. This book is obviously also intended for those who have experienced first hand pemphigus vulgaris. This book is also a suitable medium for understanding the pemphigus group. Residents and researchers in dermatology and close disciplines can use the book as a quick reference guide when dealing with these patients.

This book will help both dermatologists and non-dermatology physicians for treating each disease practically. Each chapter reviews the current literature of treatments for each disease, rates disease severity, and provides guidelines for the use of available medications. This book will help guide clinicians in carrying out suitable treatments based on the severity. The author aims to provide a quick study guide for students and a reference for physicians who practice treating these types of patients. The author hopes the reader enjoys reading this book as much as he did composing it. (Imprint: Nova Biomedical)